SCHEMBL16612868

SCHEMBL16612868

COc1ccc2c(ccn2CCn2c[c]c(C(N)=O)n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 6/20 0.49
MTNR1B P49286 6/20 0.49
HTR2C P28335 2/20 0.44
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
HTR2A P28223 1/20 0.39
ADA P00813 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
ITGB3 P05106 1/20 0.38
ITGB1 P05556 1/20 0.38
ITGAV P06756 1/20 0.38
ITGA5 P08648 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16612854 0.93 MTNR1A (0.52) MTNR1AMTNR1BHTR2CHDAC8HDAC6
SCHEMBL16612831 0.87 HCRTR2 (0.42) MTNR1AMTNR1BHDAC8HDAC6HDAC3
SCHEMBL16613000 0.87 HTR2A (0.42) MTNR1AMTNR1BHTR2CHDAC8HDAC6
SCHEMBL16612936 0.86 MTNR1A (0.50) MTNR1AMTNR1BHTR2CHCRTR2HTR2A
SCHEMBL12480072 0.84 HTR2A (0.41) HTR2CHDAC8HDAC6HDAC3HDAC1
SCHEMBL16612982 0.84 HCRTR2 (0.44) MTNR1AMTNR1BHCRTR1HCRTR2
SCHEMBL16612656 0.83 HCRTR2 (0.42) MTNR1AMTNR1BHDAC8HDAC6HDAC3
SCHEMBL16612628 0.82 HCRTR2 (0.43) MTNR1AMTNR1BHCRTR1HCRTR2
SCHEMBL16612997 0.82 HCRTR2 (0.42) MTNR1AMTNR1BHCRTR1HCRTR2NPC1
SCHEMBL16612954 0.82 LMNA (0.53) MTNR1AMTNR1BHTR2CHTR2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675801-B1 NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2015-04-08 EP disclosed